19-20625392-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001076675.3(ZNF626):c.485G>A(p.Gly162Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000684 in 1,461,766 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001076675.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ZNF626 | NM_001076675.3 | c.485G>A | p.Gly162Glu | missense_variant | 4/4 | ENST00000601440.6 | NP_001070143.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ZNF626 | ENST00000601440.6 | c.485G>A | p.Gly162Glu | missense_variant | 4/4 | 4 | NM_001076675.3 | ENSP00000469958.1 | ||
ZNF626 | ENST00000595405.1 | c.257G>A | p.Gly86Glu | missense_variant | 2/2 | 3 | ENSP00000469566.1 | |||
ENSG00000269110 | ENST00000595094.1 | n.363+20292G>A | intron_variant | 5 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 250100Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135658
GnomAD4 exome AF: 0.00000684 AC: 10AN: 1461766Hom.: 0 Cov.: 37 AF XY: 0.00000825 AC XY: 6AN XY: 727174
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 01, 2022 | The c.485G>A (p.G162E) alteration is located in exon 4 (coding exon 4) of the ZNF626 gene. This alteration results from a G to A substitution at nucleotide position 485, causing the glycine (G) at amino acid position 162 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at